AI Summary & Key Takeaways
AI InsightConclusions: It was seen that the decrease of galectin-3 levels in thyroid papillary carcinoma could be effective in the transformation from microcarcinoma to macrocarcinoma, and TTF-1 could be an important marker for the differentiation between benign and malignant thyroid nodules.
📌 3 Key Takeaways
Abstract
Aim: This study aimed to the efficiacy of usage galectin-3, hepsin, and thyroid transcription factor-1 (TTF-1) levels as markers for the differentiation between patients with malignant and benign thyroid nodules. Methods: The study was done prospectively between January 2018 and April 2018 in our clinic, in patients who were diagnosed with thyroid nodules and scheduled for surgery. Galectin-3, hepsin, and TTF-1 levels were measured in the preoperative serum of the benign and malignant groups. The measured levels were evaluated statistically to determine whether there was any significant difference between the malignant and benign groups. Results: When the levels of galectin-3, hepsin, and TTF-1 in the malignant and benign groups were compared, there was a statistically significant difference in TTF-1 levels (p=0.038). However, no significant difference was found in hepsin and galectin-3. When the macropapillary and micropapillary types were compared within the malignant patient group, there was a significant difference between the galectin-3 levels (p = 0.009), but no difference was found between hepsin and TTF-1. Conclusions: It was seen that the decrease of galectin-3 levels in thyroid papillary carcinoma could be effective in the transformation from microcarcinoma to macrocarcinoma, and TTF-1 could be an important marker for the differentiation between benign and malignant thyroid nodules.
Özet
Amaç: Çalışmada; galektin-3, hepsin ve tiroit transkripsiyon faktör-1 (TTF-1)’in kan değerlerinin tiroit nodüllerinde malign ve benign ayrımındaki tanısal değerini araştırmayı amaçladık. Yöntemler: Çalışma kliniğimizde Ocak 2018 ile Nisan 2018 tarihleri arasında tiroit nodülü nedeniyle operasyon planlanan hastalarda prospektif olarak yürütüldü. Benign ve malign grupların ameliyat öncesi elde edilen serumlarında galektin-3, hepsin ve TTF-1 seviyeleri açısından farklılık olup olmadığı istatistiksel olarak araştırıldı. Bulgular: Malign ve benign grupta ölçülen galektin-3, hepsin ve TTF-1 seviyeleri karşılaştırıldığında; TTF-1 seviyelerinde istatistiksel olarak anlamlı fark bulunurken (p=0,038), hepsin ve galektin-3’te anlamlı fark tespit edilmedi. Malign hasta grubunda makropapiller ve mikropapiller tip karşılaştırıldığında galektin-3 seviyeleri arasından anlamlı bir fark tespit edilirken (p=0,009), hepsin ve TTF-1 arasında fark tespit edilmedi. Sonuç: Tiroid papiller karsinomunda galectin-3 seviyesinin düşmesinin mikro karsinomdan makro karsinoma dönüşümde etkili olabileceği, TTF-1’ in tiroid nodüllerinde benign ve malign ayrımında önemli bir belirteç olabileceği görüldü.